Moise, Laura <br/><br/>
Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.  [electronic resource] 

 -  Leukemia & lymphoma  Mar 2011 
 - 521-4 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2010.536601  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Central Nervous System Neoplasms--drug therapy<br/>Cytarabine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Feasibility Studies<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppression Therapy--adverse effects<br/>Lymphoma--drug therapy<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Organ Transplantation--methods<br/>Recurrence<br/>Remission Induction<br/>Transplantation<br/>Treatment Outcome